LEARN THE METHOD
Evidence reading
Complex medicine questions become clearer when they are returned to checkable sources, study design and regulatory records. Every article identifies its editorial owner, review role, date and primary-source entry points.
Originator and generic medicines: start with the right question
A useful comparison starts with the approval pathway, reference product, quality standard and the regulator in the relevant market—not a blanket claim that one category is always better.
2026-08-14 · Editorial and review details →R&D READINGFrom screening to medicine: how evidence accumulates
Candidate discovery, validation, clinical research, regulatory review and post-marketing monitoring answer different questions along one development path.
2026-08-14 · Editorial and review details →MANUFACTURING & QUALITYHow medicine quality is built beyond the laboratory
Quality is not a final test at the factory gate. It is a controlled system of materials, process, facilities, records and continual improvement.
2026-08-14 · Editorial and review details →PRACTICAL READINGHow to read a medicine label
A label is not marketing material. It is a versioned regulatory record of authorised use, risks, product presentation and updates.
2026-08-14 · Editorial and review details →EVIDENCE METHODWhy medicine education begins with primary regulatory sources
Papers and reporting may provide leads; approval records, labels and regulator communications are the starting point for checking a particular product in a particular market.
2026-08-14 · Editorial and review details →R&D & QUALITYHow to read global pharma's public R&D and quality material
Public material from Roche, Pfizer, GSK, Novartis, Lilly, Johnson & Johnson, Takeda and Boehringer Ingelheim can illuminate methods, but it does not itself prove a product's effectiveness, quality or marketing status.
2026-08-14 · Editorial and review details →DOSAGE FORMS & SAFETYInjections, oral medicines, patches and modified release: dosage form is identity
The same active ingredient does not necessarily mean the same medicine. Dosage form, route, strength, presentation and market are part of every comparison.
2026-08-14 · Editorial and review details →